ION BEAM APPLICATIONS (IBAB.BR) Stock Price, Forecast & Analysis
Europe - Euronext Brussels - EBR:IBAB - BE0003766806 - Common Stock
IBAB.BR Key Statistics, Chart & Performance
The current stock price of IBAB.BR is 13.66 EUR. In the past month the price increased by 23.78%. In the past year, price increased by 7.85%.
IBAB.BR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.13 | 105.86B | ||
| 1MDT.MI | MEDTRONIC PLC | 17.08 | 105.52B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 19.67 | 53.03B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 19.62 | 52.88B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17.26 | 24.60B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.24 | 24.57B | ||
| BIM.PA | BIOMERIEUX | 27.88 | 12.74B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 145.96 | 4.39B | ||
| DIA.MI | DIASORIN SPA | 22.61 | 4.19B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 25.67 | 3.70B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 11.41 | 1.38B | ||
| DRW8.DE | DRAEGERWERK AG | 9.49 | 1.15B |
Related stock screener links
About IBAB.BR
Company Profile
Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon and currently employs 2,095 full-time employees. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
Company Info
ION BEAM APPLICATIONS
Chemin du Cyclotron 3
Louvain-la-Neuve BRABANT-WALLON BE
Employees: 1943
Phone: 3210475811
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you describe the business of ION BEAM APPLICATIONS?
Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon and currently employs 2,095 full-time employees. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
What is the stock price of ION BEAM APPLICATIONS today?
The current stock price of IBAB.BR is 13.66 EUR. The price decreased by -0.58% in the last trading session.
Does ION BEAM APPLICATIONS pay dividends?
ION BEAM APPLICATIONS (IBAB.BR) has a dividend yield of 1.26%. The yearly dividend amount is currently 0.17.
How is the ChartMill rating for ION BEAM APPLICATIONS?
IBAB.BR has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
On which exchange is IBAB.BR stock listed?
IBAB.BR stock is listed on the Euronext Brussels exchange.
What do analysts say about ION BEAM APPLICATIONS (IBAB.BR) stock?
10 analysts have analysed IBAB.BR and the average price target is 14.62 EUR. This implies a price increase of 7.03% is expected in the next year compared to the current price of 13.66.
IBAB.BR Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to IBAB.BR. When comparing the yearly performance of all stocks, IBAB.BR is one of the better performing stocks in the market, outperforming 75.27% of all stocks.
IBAB.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR. While IBAB.BR is still in line with the averages on profitability rating, there are concerns on its financial health.
IBAB.BR Financial Highlights
Over the last trailing twelve months IBAB.BR reported a non-GAAP Earnings per Share(EPS) of 0.57. The EPS increased by 112.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.85% | ||
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| Debt/Equity | 0.23 |
IBAB.BR Forecast & Estimates
10 analysts have analysed IBAB.BR and the average price target is 14.62 EUR. This implies a price increase of 7.03% is expected in the next year compared to the current price of 13.66.
For the next year, analysts expect an EPS growth of 141.9% and a revenue growth 23.68% for IBAB.BR